JILL CALHOUN: Open Payments
NPI 1053348607 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$878 in 40 payments from 14 companies in 2025. Trend: 2023 $767 · 2024 $809 · 2025 $878
Food & beverage: $878
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $141 |
| E.R. Squibb & Sons, L.L.C. | 6 | $114 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Merck Sharp & Dohme LLC | 4 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $68 |
| Amgen Inc. | 3 | $63 |
| PFIZER INC. | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $50 |
Products named: ZEPBOUND, ELIQUIS, LEQVIO, FARXIGA, VERQUVO, CAMZYOS, JARDIANCE, Repatha.
Industry payments across NC — which companies pay providers there.
